Skip to main content
Erschienen in: Brain Tumor Pathology 3/2017

25.05.2017 | Original Article

Histone H3 K27M mutations in adult cerebellar high-grade gliomas

verfasst von: Satoshi Nakata, Sumihito Nobusawa, Tatsuya Yamazaki, Tadashi Osawa, Keishi Horiguchi, Yasuhiro Hashiba, Hiroyuki Yaoita, Nozomi Matsumura, Hayato Ikota, Junko Hirato, Yuhei Yoshimoto, Hideaki Yokoo

Erschienen in: Brain Tumor Pathology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Adult cerebellar high-grade gliomas (HGG) are rare and their molecular basis has not been fully elucidated. Although a diffuse midline glioma H3 K27M-mutant, a recently characterized variant of HGG, was reported to occasionally occur in the cerebellum, adult cases were rarely tested for this mutation; only five mutant cases have been reported to date. It currently remains unknown whether H3 K27M-mutant cerebellar gliomas share common histological features or have a uniformly dismal prognosis. In the present study, we assessed the prevalence of histone H3 K27M mutations in ten adult cerebellar HGG, identifying two H3F3A-mutant cases. One case was a 70-year-old female with a cystic lesion. Histologically, the tumor was considered to be glioblastoma; however, a part of the tumor exhibiting low proliferative activity appeared to be consistent with long-standing H3 K27M-mutant tumors in the literature. Another case was a 69-year-old male. The tumor showed a distinct circumscribed histology with minimal astrocytic differentiation, suggesting a nosological issue in the diagnosis of diffuse midline glioma. More cerebellar tumors need to be tested for H3 K27M mutations to clarify the clinical and histopathological spectra of this tumor.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Adams H, Chaichana KL, Avendaño J, Liu B, Raza SM, Quiñones-Hinojosa A (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80:e237–e243CrossRefPubMedPubMedCentral Adams H, Chaichana KL, Avendaño J, Liu B, Raza SM, Quiñones-Hinojosa A (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80:e237–e243CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K (2012) Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 29:87–95CrossRefPubMed Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K (2012) Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 29:87–95CrossRefPubMed
3.
Zurück zum Zitat Jeswani S, Nuño M, Folkerts V, Mukherjee D, Black KL, Patil CG (2013) Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis. Neurosurgery 73:240–246CrossRefPubMed Jeswani S, Nuño M, Folkerts V, Mukherjee D, Black KL, Patil CG (2013) Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis. Neurosurgery 73:240–246CrossRefPubMed
4.
Zurück zum Zitat Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437CrossRefPubMed Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437CrossRefPubMed
5.
Zurück zum Zitat Hawkins CE, Ellison DW, Sturm D (2016) Diffuse midline glioma, H3 K27M-mutant. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW (eds) WHO classification of tumors of the central nervous system. IARC Press, Lyon, pp 57–59 Hawkins CE, Ellison DW, Sturm D (2016) Diffuse midline glioma, H3 K27M-mutant. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW (eds) WHO classification of tumors of the central nervous system. IARC Press, Lyon, pp 57–59
6.
Zurück zum Zitat Fontebasso AM, Schwartzentruber J, Khuong-Quang DA et al (2013) Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 125:659–669CrossRefPubMedPubMedCentral Fontebasso AM, Schwartzentruber J, Khuong-Quang DA et al (2013) Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 125:659–669CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46:462–466CrossRefPubMedPubMedCentral Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46:462–466CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Venneti S, Santi M, Felicella MM et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128:743–753CrossRefPubMedPubMedCentral Venneti S, Santi M, Felicella MM et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128:743–753CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Solomon DA, Wood MD, Tihan T et al (2016) Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26:569–580CrossRefPubMed Solomon DA, Wood MD, Tihan T et al (2016) Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26:569–580CrossRefPubMed
11.
Zurück zum Zitat Gessi M, Gielen GH, Dreschmann V, Waha A, Pietsch T (2015) High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord. Acta Neuropathol 130:435–437CrossRefPubMed Gessi M, Gielen GH, Dreschmann V, Waha A, Pietsch T (2015) High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord. Acta Neuropathol 130:435–437CrossRefPubMed
12.
Zurück zum Zitat Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro Oncol 16:140–146CrossRefPubMed Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro Oncol 16:140–146CrossRefPubMed
13.
Zurück zum Zitat Feng J, Hao S, Pan C et al (2015) The H33 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. Hum Pathol 46:1626–1632CrossRefPubMed Feng J, Hao S, Pan C et al (2015) The H33 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. Hum Pathol 46:1626–1632CrossRefPubMed
14.
Zurück zum Zitat Joyon N, Tauziède-Espariat A, Alentorn A et al (2017) K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway. Neuropathol Appl Neurobiol 43:271–276CrossRefPubMed Joyon N, Tauziède-Espariat A, Alentorn A et al (2017) K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway. Neuropathol Appl Neurobiol 43:271–276CrossRefPubMed
15.
Zurück zum Zitat Vettermann FJ, Neumann JE, Suchorska B et al (2016) K27M midline gliomas display malignant progression by imaging and histology. Neuropathol Appl Neurobiol. doi:10.1111/nan12371 Vettermann FJ, Neumann JE, Suchorska B et al (2016) K27M midline gliomas display malignant progression by imaging and histology. Neuropathol Appl Neurobiol. doi:10.​1111/​nan12371
16.
Zurück zum Zitat Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H33 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231CrossRefPubMed Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H33 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231CrossRefPubMed
17.
Zurück zum Zitat Karremann M, Rausche U, Roth D et al (2013) Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. Br J Cancer 109:844–851CrossRefPubMedPubMedCentral Karremann M, Rausche U, Roth D et al (2013) Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. Br J Cancer 109:844–851CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Nguyen AT, Colin C, Nanni-Metellus I et al (2015) Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumors. Neuropathol Appl Neurobiol 41:403–408CrossRefPubMed Nguyen AT, Colin C, Nanni-Metellus I et al (2015) Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumors. Neuropathol Appl Neurobiol 41:403–408CrossRefPubMed
19.
Zurück zum Zitat Reuss DE, Kratz A, Sahm F et al (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130:407–417CrossRefPubMed Reuss DE, Kratz A, Sahm F et al (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130:407–417CrossRefPubMed
20.
Zurück zum Zitat Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815–827CrossRefPubMedPubMedCentral Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815–827CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Chan AK, Mao Y, Ng HK (2016) TP53 and histone H33 mutations in triple-negative lower-grade gliomas. N Engl J Med 375:2206–2208CrossRefPubMed Chan AK, Mao Y, Ng HK (2016) TP53 and histone H33 mutations in triple-negative lower-grade gliomas. N Engl J Med 375:2206–2208CrossRefPubMed
22.
Zurück zum Zitat Liu B, Arakawa Y, Murata D et al (2016) Clinicopathological, radiological, and genetic analyses of cerebellar gangliogliomas with long-term survival. World Neurosurg 94:521–528CrossRefPubMed Liu B, Arakawa Y, Murata D et al (2016) Clinicopathological, radiological, and genetic analyses of cerebellar gangliogliomas with long-term survival. World Neurosurg 94:521–528CrossRefPubMed
23.
Zurück zum Zitat Pagès M, Beccaria K, Boddaert N et al (2016) Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathol. doi:10.1111/bpa12473 PubMed Pagès M, Beccaria K, Boddaert N et al (2016) Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathol. doi:10.​1111/​bpa12473 PubMed
24.
Zurück zum Zitat Nagaishi M, Nobusawa S, Yokoo H et al (2016) Genetic mutations in high grade gliomas of the adult spinal cord. Brain Tumor Pathol 33:267–269CrossRefPubMed Nagaishi M, Nobusawa S, Yokoo H et al (2016) Genetic mutations in high grade gliomas of the adult spinal cord. Brain Tumor Pathol 33:267–269CrossRefPubMed
25.
Zurück zum Zitat Reyes-Botero G, Giry M, Mokhtari K et al (2014) Molecular analysis of diffuse intrinsic brainstem gliomas in adults. J Neurooncol 116:405–411CrossRefPubMed Reyes-Botero G, Giry M, Mokhtari K et al (2014) Molecular analysis of diffuse intrinsic brainstem gliomas in adults. J Neurooncol 116:405–411CrossRefPubMed
26.
Zurück zum Zitat Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46:621–626PubMed Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46:621–626PubMed
27.
Zurück zum Zitat Ikemura M, Shibahara J, Mukasa A et al (2016) Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas. Histopathology 69:260–267CrossRefPubMed Ikemura M, Shibahara J, Mukasa A et al (2016) Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas. Histopathology 69:260–267CrossRefPubMed
28.
Zurück zum Zitat Poussaint TY, Kocak M, Vajapeyam S et al (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol 13:417–427CrossRefPubMedPubMedCentral Poussaint TY, Kocak M, Vajapeyam S et al (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol 13:417–427CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Gessi M, Capper D, Sahm F et al (2016) Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol 132:635–637CrossRefPubMed Gessi M, Capper D, Sahm F et al (2016) Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol 132:635–637CrossRefPubMed
30.
Zurück zum Zitat Hashizume R, Andor N, Ihara Y et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394–1396CrossRefPubMedPubMedCentral Hashizume R, Andor N, Ihara Y et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394–1396CrossRefPubMedPubMedCentral
31.
33.
Zurück zum Zitat Hennika T, Hu G, Olaciregui NG et al (2017) Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS One 12:e0169485CrossRefPubMedPubMedCentral Hennika T, Hu G, Olaciregui NG et al (2017) Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS One 12:e0169485CrossRefPubMedPubMedCentral
Metadaten
Titel
Histone H3 K27M mutations in adult cerebellar high-grade gliomas
verfasst von
Satoshi Nakata
Sumihito Nobusawa
Tatsuya Yamazaki
Tadashi Osawa
Keishi Horiguchi
Yasuhiro Hashiba
Hiroyuki Yaoita
Nozomi Matsumura
Hayato Ikota
Junko Hirato
Yuhei Yoshimoto
Hideaki Yokoo
Publikationsdatum
25.05.2017
Verlag
Springer Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 3/2017
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-017-0288-6

Weitere Artikel der Ausgabe 3/2017

Brain Tumor Pathology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.